Danisco delivers bio-based food ingredients to thousands of customers globally, including the world’s leading food manufacturers.
We are a First choice provider for a global food industry that is continually seeking healthy and safe ingredients founded on sustainability.
Our focus areas centre on Enablers (emulsifiers, systems and gums) that offer increased functionality to processed foods and BioActives (cultures and natural sweeteners) with both a functionality and health & nutrition profile.
Sources: Leatherhead, Danisco estimates
Danisco is an important driver of innovation and sustainability within a USD 1.5 trillion food industry.
The global food ingredients market is estimated at USD 24 billion (DKK 150 billion) and grows at around 3-5% annually.
The areas in which Danisco operates amount to around USD 10 billion (around DKK 60 billion), with Danisco as the overall largest player within this space, holding a number one or two position in each category.
Danisco’s leadership position has developed in close collaboration with our customers through SAFI, our sales and application organisation for food ingredients (including food enzymes manufactured by our Genencor division).
The food ingredients market is fairly diversified, but among our many competitors are Cargill, Kerry, Huber, Cognis, Chr. Hansen and ABF.
Learn about our food ingredients: Facts about ingredients.
The global market for industrial enzymes was estimated to be around USD 2.9 billion in 2008, growing at an average of 6-8% over an economic cycle. It is our assumption that the market grew by approximately 3% in 2009, bringing the total market to around USD 3 billion (around DKK 18 billion).
M.g. = Market growth
Sources: Freedonia, Genencor estimates
Major application areas include industries as diverse as animal nutrition, detergents, bioethanol, textile treatment, carbohydrate processing and food and beverages.
As the world’s second-largest developer and manufacturer of industrial enzymes, Genencor holds prominent market positions in all major segments.
Competitors include Novozymes, DSM, AB Enzymes, BASF, Shin-Nihon, Amano and a range of niche players. The industrial enzymes market is fairly consolidated, with Genencor and Novozymes together servicing an estimated 70% of the total market.
Genencor is a top 10 leader in global biotechnology. As a leading force in innovation into the white biotech space, Genencor addresses previously unmet needs within as well as beyond its current business areas. The Innovation and Sustainability sections of this report discuss this work in greater detail.
Learn more about our industrial enzymes.
You may also visit /cmd for access to the detailed presentation material on Genencor that we published in connection with our 2008 capital markets day for institutional investors.
To learn more about Danisco’s marketplace visit the investor section: The market.
